Presentation is loading. Please wait.

Presentation is loading. Please wait.

Protection by budesonide and fluticasone on allergen-induced airway responses after discontinuation of therapy  Padmaja Subbarao, MD, MSc, Sandra C. Dorman,

Published bySamuel Anthony Hoover Modified over 5 years ago

Similar presentations

Presentation on theme: "Protection by budesonide and fluticasone on allergen-induced airway responses after discontinuation of therapy  Padmaja Subbarao, MD, MSc, Sandra C. Dorman,"— Presentation transcript:

1 Protection by budesonide and fluticasone on allergen-induced airway responses after discontinuation of therapy  Padmaja Subbarao, MD, MSc, Sandra C. Dorman, PhD, Tracey Rerecich, CMLT, Richard M. Watson, BSc, Gail M. Gauvreau, PhD, Paul M. O'Byrne, MB  Journal of Allergy and Clinical Immunology  Volume 115, Issue 4, Pages (April 2005) DOI: /j.jaci Copyright © 2005 American Academy of Allergy, Asthma and Immunology Terms and Conditions

2 Fig 1 The maximal allergen-induced EAR (mean ± SEM) was significantly attenuated by fluticasone but not by budesonide when compared with placebo. No difference in attenuation was detectable between budesonide and placebo. The maximal allergen-induced LAR (mean ± SEM) was significantly attenuated by both fluticasone and budesonide when compared with placebo. No difference in attenuation was detectable between fluticasone and budesonide. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2005 American Academy of Allergy, Asthma and Immunology Terms and Conditions

3 Fig 2 Airway responsiveness (MCh PC20 expressed as geometric mean ± geometric SEM) for before treatment (BL), 7 days after treatment (pre allergen), and 24 hours after allergen inhalation (post allergen). Airway responsiveness improved from baseline to before allergen with inhaled steroid but not placebo treatment. However, the airway responsiveness significantly worsened in all groups, despite treatment after allergen challenge. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2005 American Academy of Allergy, Asthma and Immunology Terms and Conditions

4 Fig 3 Changes in sputum eosinophils (mean percentage ± SEM) between 7 days after treatment (pre allergen) and 24 hours after allergen inhalation (post allergen). The allergen-induced increase in the number of sputum eosinophils was significantly decreased with fluticasone and budesonide treatment compared with placebo treatment. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2005 American Academy of Allergy, Asthma and Immunology Terms and Conditions

Download ppt "Protection by budesonide and fluticasone on allergen-induced airway responses after discontinuation of therapy  Padmaja Subbarao, MD, MSc, Sandra C. Dorman,"

Similar presentations

Bronchial challenges in athletes applying to inhale a β2-agonist at the 2004 Summer Olympics Sandra D. Anderson, PhD, DSc, Malcolm Sue-Chu, MB ChB, PhD,

Bronchial challenges in athletes applying to inhale a β2-agonist at the 2004 Summer Olympics Sandra D. Anderson, PhD, DSc, Malcolm Sue-Chu, MB ChB, PhD,
Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.

Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5- year follow-up: Effectiveness of early intervention with budesonide in.

The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5- year follow-up: Effectiveness of early intervention with budesonide in.
The effects of an anti–IL-13 mAb on cytokine levels and nasal symptoms following nasal allergen challenge  Grant C. Nicholson, BSc, Harsha H. Kariyawasam,

The effects of an anti–IL-13 mAb on cytokine levels and nasal symptoms following nasal allergen challenge  Grant C. Nicholson, BSc, Harsha H. Kariyawasam,
Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery  Albertien A.C. Aukema,

Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery  Albertien A.C. Aukema,
Allergen immunotherapy: A practice parameter third update

Allergen immunotherapy: A practice parameter third update
Jessica P. Hollenbach, PhD, Michelle M. Cloutier, MD 

Jessica P. Hollenbach, PhD, Michelle M. Cloutier, MD 
Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma  Virginia Norris, MRCP, Lee Choong, BSc, Duyen Tran,

Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma  Virginia Norris, MRCP, Lee Choong, BSc, Duyen Tran,
The prevalence of severe refractory asthma

The prevalence of severe refractory asthma
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Exposure of infants to budesonide through breast milk of asthmatic mothers  Anette Fält, BSc, Thomas Bengtsson, MSc, Britt-Marie Kennedy, BSc, Ann Gyllenberg,

Exposure of infants to budesonide through breast milk of asthmatic mothers  Anette Fält, BSc, Thomas Bengtsson, MSc, Britt-Marie Kennedy, BSc, Ann Gyllenberg,
Sputum indoleamine-2, 3-dioxygenase activity is increased in asthmatic airways by using inhaled corticosteroids  Kittipong Maneechotesuwan, MD, PhD, Sirinya.

Sputum indoleamine-2, 3-dioxygenase activity is increased in asthmatic airways by using inhaled corticosteroids  Kittipong Maneechotesuwan, MD, PhD, Sirinya.
Protective effect of inhaled budesonide against unlimited airway narrowing to methacholine in atopic patients with asthma  Patrick Booms, MSca, David.

Protective effect of inhaled budesonide against unlimited airway narrowing to methacholine in atopic patients with asthma  Patrick Booms, MSca, David.
Is 9 more than 2 also in allergic airway inflammation?

Is 9 more than 2 also in allergic airway inflammation?
Safety of allergen immunotherapy: A 10-year prospective study

Safety of allergen immunotherapy: A 10-year prospective study
Natural regulatory T cells in isolated early responders compared with dual responders with allergic asthma  Takashi Kinoshita, MD, Adrian Baatjes, MSc,

Natural regulatory T cells in isolated early responders compared with dual responders with allergic asthma  Takashi Kinoshita, MD, Adrian Baatjes, MSc,
The effect of montelukast, budesonide alone, and in combination on exercise-induced bronchoconstriction  MyLinh Duong, MBBS, Reshma Amin, MD, Adrian J.

The effect of montelukast, budesonide alone, and in combination on exercise-induced bronchoconstriction  MyLinh Duong, MBBS, Reshma Amin, MD, Adrian J.
Oral corticosteroids decrease eosinophil and CC chemokine expression but increase neutrophil, IL-8, and IFN-γ–inducible protein 10 expression in asthmatic.

Oral corticosteroids decrease eosinophil and CC chemokine expression but increase neutrophil, IL-8, and IFN-γ–inducible protein 10 expression in asthmatic.
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J

Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
Thymic stromal lymphopoietin and IL-33 modulate migration of hematopoietic progenitor cells in patients with allergic asthma  Steven G. Smith, PhD, Akash.

Thymic stromal lymphopoietin and IL-33 modulate migration of hematopoietic progenitor cells in patients with allergic asthma  Steven G. Smith, PhD, Akash.

Similar presentations

Ads by Google